MiR-218 microRNA precursor family
MiR-218 microRNA precursor family is a group of related microRNA sequences that play a crucial role in the regulation of gene expression in multicellular organisms. The miR-218 family is involved in various biological processes, including development, cell proliferation, apoptosis, and cancer progression. This article provides an overview of the miR-218 microRNA precursor family, including its structure, function, and involvement in human diseases.
Structure and Function[edit | edit source]
The miR-218 microRNA precursor family is composed of short, non-coding RNA molecules that are approximately 22 nucleotides in length. These microRNAs are transcribed from DNA but do not encode proteins. Instead, they function to regulate gene expression at the post-transcriptional level. MiR-218 is processed from a longer precursor molecule known as a primary microRNA (pri-miRNA) to a precursor microRNA (pre-miRNA) and finally to the mature miR-218 molecule.
MiR-218 targets the 3' untranslated regions (3' UTRs) of specific messenger RNAs (mRNAs), leading to their degradation or inhibition of translation. Through this mechanism, miR-218 plays a critical role in controlling the expression levels of various genes involved in cell differentiation, proliferation, and apoptosis.
Role in Development and Disease[edit | edit source]
MiR-218 has been implicated in a wide range of biological processes and diseases. It is known to play a significant role in the development of the nervous system, where it influences neural differentiation and axon guidance. Aberrant expression of miR-218 has been associated with several types of cancer, including lung cancer, colorectal cancer, and glioblastoma. In these contexts, miR-218 can function as either a tumor suppressor or an oncogene, depending on the target genes it regulates.
In addition to its role in cancer, miR-218 has been linked to cardiovascular diseases, such as heart failure and atherosclerosis. It is believed that miR-218 contributes to the pathogenesis of these conditions by regulating the expression of genes involved in endothelial function, inflammation, and lipid metabolism.
Research and Therapeutic Potential[edit | edit source]
Given its involvement in critical cellular processes and disease, miR-218 has emerged as a potential biomarker for the diagnosis and prognosis of various conditions. Furthermore, modulating the levels of miR-218 through synthetic mimics or inhibitors offers a promising therapeutic strategy for diseases associated with its dysregulation. Ongoing research aims to better understand the regulatory networks of miR-218 and to develop targeted therapies that can modulate its activity in a disease-specific manner.
Conclusion[edit | edit source]
The miR-218 microRNA precursor family plays a vital role in the regulation of gene expression, influencing a wide range of biological processes and diseases. Its potential as a biomarker and therapeutic target highlights the importance of further research into the mechanisms of miR-218 regulation and function.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD